Raymond W. Urbanski's Net Worth
$2.86 Million
Who is Raymond W. Urbanski?
Raymond W. Urbanski has an estimated net worth of $2.86 Million. This is based on reported shares across multiple companies, which include MANNKIND CORP, Applied BioSciences Corp., GT Biopharma, Inc., and SOLENO THERAPEUTICS INC.
SEC CIK
Raymond W. Urbanski's CIK is 0001653096
Past Insider Trading and Trends
2016 was Raymond W. Urbanski's most active year for acquiring shares with 1 total transactions. Raymond W. Urbanski's most active month to acquire stocks was the month of January. 2017 was Raymond W. Urbanski's most active year for disposing of shares, totalling 1 transactions. Raymond W. Urbanski's most active month to dispose stocks was the month of January. 2016 saw Raymond W. Urbanski paying a total of $403,788.00 for 438,900 shares, this is the most they've acquired in one year. In 2017 Raymond W. Urbanski cashed out on 296 shares for a total of $340.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MANNKIND CORP (MNKD) Snapshot price: $5.85
Corp VP, CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.19% | -296.00 |
$1.15 | -$340.40 | 2.92K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Applied BioSciences Corp. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GT Biopharma, Inc. (GTBP) Snapshot price: $2.1
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.58% | -176.98K |
—
| -$176.98 | 1.35M |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SOLENO THERAPEUTICS INC (SLNO) Snapshot price: $48.54
CHIEF DEVELOPMENT OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||